Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Dose and Paradoxical Reactions in Pediatric Endoscopy
NCT06419543Completed
- Sponsor
- Tongji Hospital
- Start
- May 2024
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in Procedural sedation (PS) (3 arms), sponsored by Tongji Hospital. Primary endpoint: Incidence of paradoxical reaction. Started May 2024; status: completed.
02
Drugs
remimazolam
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT06419543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06419543.